Latest

Sep 24, 2020, 07:30 ET InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

VANCOUVER, BC, Sept. 24, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases ...


Sep 22, 2020, 07:30 ET InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing

TSX:IN OTCQX:IMLFF VANCOUVER, BC, Sept. 22, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN) (OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications...


Sep 08, 2020, 07:30 ET InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update

VANCOUVER, BC, Sept. 8, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases...


Sep 02, 2020, 07:30 ET InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 2020

TSX:IN OTCQX:IMLFF VANCOUVER, BC, Sept. 2, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical stage pharmaceutical company developing medications...


Jul 07, 2020, 07:30 ET InMed Announces Dosing Initiation in 2nd Phase 1 trial with INM-755

TSX:IN OTCQX:IMLFF VANCOUVER, BC, July 7, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications...


Jun 30, 2020, 18:18 ET InMed Announces Completion of Share Consolidation

Trading of Consolidated Shares on TSX Expected to Begin on July 3rd, 2020 VANCOUVER, BC, June 30, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN) (OTCQX:IMLFF), a...


Jun 24, 2020, 07:30 ET InMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System

VANCOUVER, BC, June 24, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases...


Jun 19, 2020, 18:20 ET InMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation

VANCOUVER, BC, June 19, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases...


May 27, 2020, 07:30 ET InMed Releases CBN Preclinical Results in Glaucoma

VANCOUVER, May 27, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with...


May 19, 2020, 07:30 ET InMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family

VANCOUVER, May 19, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with...


May 14, 2020, 07:30 ET InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

VANCOUVER, May 14, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with...


May 12, 2020, 07:30 ET InMed Files PCT Patent Application for Neuroprotection in Glaucoma

VANCOUVER, May 12, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with...


May 08, 2020, 07:30 ET InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020

VANCOUVER, May 8, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high ...


May 07, 2020, 07:30 ET InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference

VANCOUVER, May 7, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with...


May 05, 2020, 07:30 ET InMed and Almac Group Developing Improved Cannabinoid Production Methods

VANCOUVER, May 5, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high ...


Apr 30, 2020, 07:30 ET InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755

VANCOUVER, April 30, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with ...


Apr 01, 2020, 07:30 ET InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

VANCOUVER, April 1, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with...


Mar 24, 2020, 07:30 ET InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial

VANCOUVER, March 24, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with...


Mar 20, 2020, 07:30 ET InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak

VANCOUVER, March 20, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with...


Mar 10, 2020, 13:24 ET InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

VANCOUVER, March 10, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with...


Feb 14, 2020, 07:30 ET InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

- Commenced Dosing of Patients in Phase 1 Clinical Trial with INM-755 - VANCOUVER, Feb. 14, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage...


Feb 07, 2020, 07:30 ET InMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020

VANCOUVER, Feb. 7, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with...


Jan 21, 2020, 07:30 ET InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview

VANCOUVER, Jan. 21, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with ...


Jan 20, 2020, 07:30 ET InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials

VANCOUVER, Jan. 20, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases...


Jan 16, 2020, 07:30 ET InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress

VANCOUVER, Jan. 16, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications...